Fatal Mitochondrial Disease Due To Combined Oxidative Phosphorylation Defect Type 3

Watchlist
Retrieved
2021-01-23
Source
Trials
Genes

Combined oxidative phosphorylation deficiency type 3 is an extremely rare clinically heterogenous disorder described in about 5 patients to date. Clinical signs included hypotonia, lactic acidosis, and hepatic insufficiency, with progressive encephalomyopathy or hypertrophic cardiomyopathy.